Phase 4
N=70
Telephone Based Management of Hyperlipidemia
Hyperlipidemia
Bottom Line
View on ClinicalTrials.gov: NCT01212159 ↗Enrolled (actual)
70
Serious AEs
2.9%
Results posted
Sep 2015
Primary outcome: Primary: LDL Level Change From Baseline — -63.4; -54.6 mg/dl — p=0.391
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Self Monitoring Lipid Analyzer (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Temple University
- Primary completion
- Jul 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY LDL Level Change From Baseline |
-63.4; -54.6 | 0.391 |
| SECONDARY Medication Compliance |
2.4; 2.4 | — |
| SECONDARY LDL Values at Two Week Interval |
96.3; 92.4; 118.6 | — |
Summary
The purpose of the study is to demonstrate that systematic self measurement of blood lipids reduces LDL cholesterol more effectively than standard care. The hypothesis is that cholesterol lowering medication adherence will be improved with self monitoring and reporting of frequent blood lipids and the percentage of patients achieving LDL goal will be greater than without home monitoring.
Eligibility Criteria
Inclusion Criteria
- LDL > 130mg/dl
Exclusion Criteria
- Pregnant patients
- liver disease
- allergic reaction to statins
Data sourced from ClinicalTrials.gov (NCT01212159). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.